Conference
649 Phase 1/2 study of AgenT-797, an allogeneic invariant natural killer T (iNKT) cell therapy, in subjects with moderate to severe acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 (COVID-19)
| العنوان: | 649 Phase 1/2 study of AgenT-797, an allogeneic invariant natural killer T (iNKT) cell therapy, in subjects with moderate to severe acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 (COVID-19) |
|---|---|
| المؤلفون: | Purbhoo, Marco, Yigit, Burcu, Michelet, Xavier, Smith, Rachel, Moskowitz, Darrian, Kirby, Maurice, Buffa, Alexa, Munari, Sonia De, Feliu, Waldo Ortuzar, Besien, Koen Van, Stevens, Don, Exley, Mark, Hammond, Terese |
| المصدر: | Regular and Young Investigator Award Abstracts ; page A680-A680 |
| بيانات النشر: | BMJ Publishing Group Ltd |
| سنة النشر: | 2022 |
| نوع الوثيقة: | conference object |
| اللغة: | unknown |
| DOI: | 10.1136/jitc-2022-sitc2022.0649 |
| DOI: | 10.1136/jitc-2022-SITC2022.0649 |
| الاتاحة: | http://dx.doi.org/10.1136/jitc-2022-sitc2022.0649 https://syndication.highwire.org/content/doi/10.1136/jitc-2022-SITC2022.0649 |
| رقم الانضمام: | edsbas.74C58396 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/jitc-2022-sitc2022.0649 |
|---|